The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits
- PMID: 3820091
- DOI: 10.1007/BF01067965
The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits
Abstract
Methods based on moment analysis are described which permit the calculation of the fundamental parameters of reversible drug/metabolite systems. These parameters include the four essential clearances of reversible and irreversible elimination, the central and steady-state distributional volumes, and the sojourn times or turnover rates of the metabolic pair. Additional parameters unique to interconversion systems are developed which describe the properties of metabolic entrapment ("recycled fraction"), conservation ("exposure enhancement"), and equilibrium resulting from reversible metabolism ("Percent parent drug at steady-state"). Parameters obtained by these methods are compared to those generated by conventional mammillary analysis. The influence of perturbation of essential parameters on the response of mammillary descriptors and the state of the interconversion system are simulated. The interconversion analysis is applied to disposition data for methylprednisolone and methylprednisone in the rabbit. Mammillary methods underestimate the metabolic clearance of these two steroids by 30%, while steroid turnover is underestimated by 100%. The steady-state volumes of distribution of the two steroids are overestimated by 10 and 61%. Additional literature data for disposition of several corticosteroids in various species and disease states are reanalyzed. Examination of cortisol/cortisone disposition in thyroid disorders reveals that mammillary methods detect the overall acceleration of steroid elimination in hyperthyroidism, but fail to reveal a 50% reduction in metabolite backconversion and decreased metabolic cycling. These moment analysis methods should facilitate characterization of the pharmacokinetics of the increasing array of reversible drug/metabolite systems.
Similar articles
-
Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.Pharm Res. 1990 Oct;7(10):1003-10. doi: 10.1023/a:1015930831024. Pharm Res. 1990. PMID: 2281028
-
Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar;12(1):50-7. doi: 10.1007/BF03189861. Eur J Drug Metab Pharmacokinet. 1987. PMID: 3497038
-
Bioavailability and nonlinear disposition of methylprednisolone and methylprednisone in the rat.J Pharm Sci. 1992 Feb;81(2):117-21. doi: 10.1002/jps.2600810203. J Pharm Sci. 1992. PMID: 1545348
-
Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance.Pharmacol Rev. 2023 May;75(3):416-462. doi: 10.1124/pharmrev.121.000524. Epub 2023 Jan 10. Pharmacol Rev. 2023. PMID: 36627211 Review.
-
Understanding the pharmacokinetics of reversible metabolism.Transl Clin Pharmacol. 2019 Jun;27(2):52-58. doi: 10.12793/tcp.2019.27.2.52. Epub 2019 Jun 28. Transl Clin Pharmacol. 2019. PMID: 32055581 Free PMC article. Review.
Cited by
-
Pharmacokinetics of haloperidol.Clin Pharmacokinet. 1989 Dec;17(6):396-423. doi: 10.2165/00003088-198917060-00004. Clin Pharmacokinet. 1989. PMID: 2689040 Review.
-
Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.J Pharmacokinet Biopharm. 1990 Oct;18(5):401-21. doi: 10.1007/BF01061702. J Pharmacokinet Biopharm. 1990. PMID: 2266496
-
Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.Pharm Res. 1991 Apr;8(4):508-11. doi: 10.1023/a:1015811514050. Pharm Res. 1991. PMID: 1871048
-
Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6.Eur J Clin Pharmacol. 1993;44(5):433-8. doi: 10.1007/BF00315539. Eur J Clin Pharmacol. 1993. PMID: 8359179 Clinical Trial.
-
Reversible metabolism of vitamin K-vitamin K epoxide: modeling considerations and limitations.J Pharmacokinet Biopharm. 1992 Feb;20(1):1-18. doi: 10.1007/BF01143184. J Pharmacokinet Biopharm. 1992. PMID: 1588501
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical